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Idiopathic pulmonary alveolar proteinosis (PAP) is a rare disease due to impaired alveolar macrophage
function caused by neutralising anti-granulocyte-macrophage colony-stimulating autoantibodies. A
nineteen years old male patient was admitted with the complaints of cough, sputum production,
dyspnea and fever. There were bilaterally inspiratory ﬁne crackles. The chest radiographs showed
bilateral air-space consolidation. On thorax computed tomography; pre-carinal lymph nodes enlarge-
ment, ground glass opacities, septal thickening and crazy-paving appearance were determined.
Bronchoalveolar lavage was performed and reported was PAP.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Pulmonary alveolar proteinosis (PAP) is an unusual lung
disorder of unknown etiology characterized by the accumulation of
large amounts of a phospholipoproteinaceous material in the
alveoli that stains positive by using the periodic acid-Schiff (PAS)
method.1,2
More recently, the role of granulocyte-macrophage colony-
stimulating factor (GM-CSF) has been described in the pathogenesis
of the PAP.2 A deﬁciency in GM-CSF activity results in defective
macrophages and reduced clearance of surfactant from the lungs.1,3
Anti–GM-CSF antibodies have also been found in most patients.4
There are three different types of PAP: congenital PAP (2% of
total cases), secondary PAP (less than 10% of total cases), and
acquired or adult-type PAP (90% of cases).3,5 More than 90% of cases
of PAP occur as a primary acquired disorder of unknown etiology,
not associated with any familial predisposition.4,5
Diagnosis of the disease may be difﬁcult with clinical sings and
symptoms. Currently, there is no curative treatment of the
disease.1,2,5 We presented a case of primary PAP who had dishar-
mony between clinical and radiological ﬁndings.Faculty, Department of Chest
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rved.2. Case
A nineteen years old male patient was admitted to our clinic
with the complaints of cough, sputum production, mild dyspnea on
exertion and fever in the last 2 days. In the history of the patient,
there was not any disease. The physical examination revealed
bilaterally inspiratory ﬁne crackles on auscultation. The chest
radiographs showed bilateral air-space consolidation, prominent in
the bases (Fig. 1a). The patient was a non smoker and had no
environmental and occupational organic or inorganic dust expo-
sure. Complete blood count revealed WBC 11.0 K/UL, RBC 4.73 M/
UL, Hemoglobin 16.1 g/dl, Hematocrit 44.7%, Platelet 221 K/UL.
Erytrocyte sedimentation rate was 23 mm/h, C-reactive protein
21.8 mg/L, lactate dehydrogenase (LDH) 401 U/L. Tumour markers
and the other laboratory parameters were within normal limits.
The serology of HIV was negative. The pulmonary function tests of
the case showed FVC 4.98 L (99%), FEV1: 4.30 L (%101), FEV1/FVC:
86%, DLCO: 8.21 mmol/kPa/min (70%), TLC: 6.15 L (90%), RV: 1,81 L
(113%), RV/TLC: 29%. Arterial blood gases analysis presented mild
hypoxemia (pH: 7.41, pCO2: 39.5 mmHg, pO2: 70.1 mmHg, HCO3:
24.7 mmol/L). Sputum examinations and cultures for M. tubercu-
losis and other bacteria were negative. On thorax computed
tomography; pre-carinal lymph nodes enlargement, bilateral
ground glass opacities, septal thickening and ‘‘crazy-paving’’
appearance were determined (Fig. 1b,c). The bronchoscopic
appearance of airways was normal. Bronchoalveolar lavage (BAL)
was performed and the appearance of BAL ﬂuid was milky. The
cytology of BAL ﬂuid reported was consistent with PAP. Other
possible diseases were excluded with clinical, laboratory and
radiological examinations.
Fig. 1. a. The chest radiographs show bilateral air-space consolidation, prominent in
the bases. b. There is pre-carinal lymph nodes enlargement on thorax computed
tomography. c. There are bilateral ground glass opacities, septal thickening and ‘‘crazy-
paving’’ appearance on thorax computed tomography.
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PAP is a disease of impaired alveolarmacrophage function leading
to excessive accumulation of surfactant components in the alveoli.1
Incidence of the disease is 4 times higher in males than
females1,5; our case was male. Patients are typically aged
20–50 years at presentation,1,2 our case was 19 years old. Physical
ﬁndings are usually nonspeciﬁc.1 The physical examination of our
case revealed bilaterally inspiratory ﬁne crackles. There was no
deﬁnite lobar or zonal predominance on chest X-ray.5 The chest
X-ray of the case showed bilateral air-space consolidation, prom-
inent in the bases. Although the ‘‘crazy-paving’’ appearance has
been considered to be strongly suggestive of alveolar proteinosis,
recent studies have reported that the crazy-paving pattern on
thin-section CT scans is a nonspeciﬁc ﬁnding.6,7 Bilateral ground
glass opacities, septal thickening, ‘‘crazy-paving’’ appearance and
para-tracheal lymph nodes enlargement were determined on
64 row multidetector computed tomography of the case. Lymph
node enlargement is uncommon in patients with pulmonary
alveolar proteinosis.8 We are of opinion that LAP sign was coinci-
dental because laboratory studies for infectious agents could not
detect any microorganisms.
Seymour et al. reported a series of 410 cases; the median
duration of symptoms before diagnosis was 7 months.5 Interest-
ingly the symptoms of our case started only 2 days before.
Seymour et al. reported that the mean  SD PaO2 at diagnosis
was 58.6  15.8 mmHg5 PaO2 of our case was 70 mmHg. PAP
patients have a mean SD LDH level that is 168 66% of the upper
limit of the normal range.5 The level of LDH was 401 U/L at
diagnosis of our case.
Three different types of PAP have been identiﬁed: congenital,
secondary and primary PAP.2 Since no other diseases were evalu-
ated, the patient was diagnosed as primary PAP; because, the
patient was a non smoker and had no environmental and occupa-
tional exposure.
The consolidation is usually bilateral and patchy. In some
patients, it is very extensive, despite relatively mild respiratory
symptoms.1 Although the clinical symptoms of our case were mild,
bilateral diffuse ground glass consolidation was found in radio-
logical examination.
On pulmonary function testing, the most common pattern seen
is that of a restrictive defect, with a disproportionate reduction in
diffusing capacity relative to modest impairment of vital capacity.5
We detected normal spirometri results with mild reduction of
diffusion capacity for DLCO by the pulmonary function testing of our
patient.
Anti–GM-CSF antibodies have been found in most patients.2
Since Anti–GM-CSF antibodies have not been available until now in
our country, we could not study on these antibodies. Serum
immunoglobulin levels have been reported to be reduced in 4% of
patients tested.5 Serum immunoglobulin levels of our case were
within normal limits. Also, the serum autoimmune marker levels
were within normal limits.
Wang et al. suggested that actual lung tissue, obtained via
transbronchial biopsy or open lung biopsy, remains the ‘‘gold
standard’’ of diagnosis but is not necessary except in problematic
cases.9 They proposed that, when several clinical features (eg,
symptoms, laboratory test results, chest radiographs, and HRCT
ﬁndings) suggest PAP, BAL alone was generally sufﬁcient to exclude
other conditions.9 According to clinical symptoms, blood gases
results, radiologic ﬁndings, BAL ﬁndings and exclusion criteria for
other possible diseases; our presented case was considered PAP.
Kariman et al. suggested that patients with an arterial partial
pressure of oxygen (PaO2) of greater than 70 mm Hg or P(A–a)O2
gradient of less than 40 mm Hg are more likely to improve
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intervals.
4. Conclusion
Although the radiological ﬁndings are very extensive in some
PAP patients, the respiratory symptoms may be relatively mild.
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